
Your generous year-end donation will be matched $1 for $1 DONATE
News


NCCS Submits Comments in Follow-Up to FDA Patient-Focused Public Meeting
NCCS submitted comments to the Food and Drug Administration (FDA) as a follow-up to the Lung Cancer Patient-Focused Drug Development…

NCCS Joins Patient Advocate Colleagues in Commenting on FDA Document on Expedited Programs for Serious Conditions
NCCS joined its patient advocate colleagues in the Cancer Leadership Council in comments on a Food and Drug Administration (FDA) document…

IOM Releases “Partnering with Patients” Meeting Summary
The Institute of Medicine released a meeting summary today of a workshop that took place in February, "Partnering with Patients to…

JAMA Opinion Piece: The Short and Long Term Implications of Myriad Decision
On June 13, 2013, the Supreme Court ruled in Association for Molecular Pathology v. Myriad Genetics that a human gene removed from…

Jessie Gruman’s New York Times Blog Describes Patient’s Post-Discharge Experience
Jessie Gruman offers her fellow cancer survivors and their caregivers specific advice for improving the discussion that occurs between…

The Definition of “Cancer”: JAMA Opinion Piece Triggers Medical, Scientific, and Policy Debate
With the online publication of an opinion piece in the Journal of the American Medical Association, Drs. Laura J. Esserman, Ian M.…

NCCS Comments on Quality Measures for PPS-Exempt Cancer Hospitals
NCCS filed comments in support of proposed cancer care quality measures that will be utilized to assess the cancer care provided by…